© 2020 MJH Life Sciences™ and Managed Healthcare Executive. All rights reserved.
Dermatology
Seven diseases benefiting from genetic tests
March 01, 2018
Genetic testing is playing a growing role in diagnosing and treating diseases, particularly when it comes to certain cancers and rheumatic conditions.
Rotational therapies aid in treating psoriasis
September 01, 2005
Mild to moderate psoriasis is generally treated first with topical corticosteroids and other topical remedies. When the disease is widespread or unresponsive to topical agents, ultraviolet phototherapy may be used at home or in the physician's office.
Medication, self-monitoring recommended to control asthma
November 01, 2004
Several drug regimens are available for asthmatics, but the key to asthma control is to reduce airway inflammation, and therefore limit the need for short-term rescue medications.
Moderate allergies effectively treated with intranasal corticosteroids
June 01, 2004
Second-generation antihistamines bestfor mild allergies; plans curb use of leukotriene modifiers
Taking what is preventable out of society
March 01, 2004
Later this year, U.S. Surgeon General Dr. Richard Carmona will release a report, "The Health Consequences of Smoking," and a new database of medical research, treatment and smoking prevention information. This year's report will come 40 years after Americans first learned there were significant consequences of smoking, thanks to the efforts of then-Surgeon General Dr. Luther Terry, who was appointed during the Kennedy administration.
February FDA Pipeline
February 01, 2004
New indications and new combinations; first-time generic approvals
New medications for rheumatoid arthritis are effective but expensive
January 01, 2004
First line treatment usualy begins with NSAIDs plus a DMARD, but combination therapy and new biologics hold great promise
December FDA Pipeline
December 01, 2003
New molecular entities and new formulations, FDA actions and generic approvals
Singling out members with less-prevalent diseases is no longer a rarity for plans
November 01, 2003
Effective rare-disease management programs promise plans cost-effective care, better quality of life for patients
Consider efficacy, effectiveness, safety to prove all-around value of a drug
May 01, 2003
FMCP model urges plans to think outside the cost silo when making formulary decisions